WallStreetZenWallStreetZen

NASDAQ: CCXI
Chemocentryx Inc Stock

Buy CCXI
$50.79-0.10 (-0.2%)
Updated Aug 9, 2022
CCXI Price
$50.79
Fair Value Price
$51.84
Market Cap
$3.62B
52 Week Low
$13.11
52 Week High
$50.94
P/E
-26.87x
P/B
15.32x
P/S
47.35x
PEG
N/A
Dividend Yield
N/A
Revenue
$37.28M
Earnings
-$133.09M
Gross Margin
96.5%
Operating Margin
-350.32%
Profit Margin
-357%
Debt to Equity
0.77
Operating Cash Flow
-$53M
Beta
1.17
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CCXI Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CCXI scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CCXI ($50.79) is undervalued by 2.02% relative to our estimate of its Fair Value price of $51.84 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CCXI ($50.79) is not significantly undervalued (2.02%) relative to our estimate of its Fair Value price of $51.84 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CCXI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CCXI due diligence checks available for Premium users.

CCXI News

Valuation

CCXI fair value

Fair Value of CCXI stock based on Discounted Cash Flow (DCF)
Price
$50.79
Fair Value
$51.84
Undervalued by
2.02%
CCXI ($50.79) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CCXI ($50.79) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CCXI is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CCXI price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-26.87x
Industry
-5.67x
Market
32.55x

CCXI price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
15.32x
Industry
4.77x
CCXI is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CCXI's financial health

Profit margin

Revenue
$11.8M
Net Income
-$31.7M
Profit Margin
-269.1%
CCXI's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CCXI's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$419.4M
Liabilities
$182.9M
Debt to equity
0.77
CCXI's short-term assets ($345.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CCXI's short-term assets ($345.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CCXI's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CCXI's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$26.1M
Investing
$28.1M
Financing
$1.9M
CCXI's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CCXI vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CCXI$3.62B-0.20%-26.87x15.32x
RARE$3.60B-2.39%-7.02x5.31x
CERT$3.65B-5.35%-253.78x3.48x
PTCT$3.70B-3.16%-6.61x-20.31x
GLPG$3.50B-1.53%N/A1.24x

Chemocentryx Stock FAQ

What is Chemocentryx's quote symbol?

NASDAQ: CCXI) Chemocentryx trades on the NASDAQ under the ticker symbol CCXI. Chemocentryx stock quotes can also be displayed as NASDAQ: CCXI.

If you're new to stock investing, here's how to buy Chemocentryx stock.

What is the 52 week high and low for Chemocentryx (NASDAQ: CCXI)?

(NASDAQ: CCXI) Chemocentryx's 52-week high was $50.94, and its 52-week low was $13.11. It is currently -0.29% from its 52-week high and 287.41% from its 52-week low.

How much is Chemocentryx stock worth today?

(NASDAQ: CCXI) Chemocentryx currently has 71,355,872 outstanding shares. With Chemocentryx stock trading at $50.79 per share, the total value of Chemocentryx stock (market capitalization) is $3.62B.

Chemocentryx stock was originally listed at a price of $11.00 in Feb 8, 2012. If you had invested in Chemocentryx stock at $11.00, your return over the last 10 years would have been 361.73%, for an annualized return of 16.53% (not including any dividends or dividend reinvestments).

How much is Chemocentryx's stock price per share?

(NASDAQ: CCXI) Chemocentryx stock price per share is $50.79 today (as of Aug 9, 2022).

What is Chemocentryx's Market Cap?

(NASDAQ: CCXI) Chemocentryx's market cap is $3.62B, as of Aug 10, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Chemocentryx's market cap is calculated by multiplying CCXI's current stock price of $50.79 by CCXI's total outstanding shares of 71,355,872.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.